COVID vaccine trials at AMU medical college
[ad_1]
One thousand volunteers have been invited to enrol in a collection of large-scale medical trials aimed at evaluating the protection and efficacy of Covaxine, Hyderabad-based Bharat Biotech-led Coronavirus vaccine at the Jawaharlal Nehru Medical College and Hospital (JNMCH), Aligarh Muslim University (AMU).
The medical trials will start from November 14 and proceed until the top of January, an official launch mentioned.
JNMC has enhanced the preparations for the trials after a nod from the Indian Council of Medical Research (ICMR).
AMU acquired the affirmation to start the medical trials from ICMR on Friday after a number of days of correspondence, mentioned Vice-Chancellor Tariq Mansoor.
Appealing volunteers from all age teams and socio-economic strata to take part within the medical trials, Prof. Mansoor mentioned, “By volunteering for a trial or study, you get a chance to participate in groundbreaking research and contribute to developing better cures and treatment options. People from various backgrounds are invited to be part of the solution and help end the pandemic.”
“An ethical committee comprising doctors, social workers and lawyers has already been constituted to manage the clinical trials,” mentioned Shahid Ali Siddiqui, Principal, JNMC.
During the human testing for vaccine, its efficacy can be evaluated in numerous methods. The earlier medical trials will search for the manufacturing of antibodies in opposition to the virus, whereas the late-phase trials will consider whether or not it actually prevents individuals from getting sick.
A letter from the Editor
Dear subscriber,
Thank you!
Your assist for our journalism is invaluable. It’s a assist for fact and equity in journalism. It has helped us preserve apace with occasions and happenings.
The Puucho has at all times stood for journalism that’s within the public curiosity. At this troublesome time, it turns into much more necessary that we have now entry to info that has a bearing on our well being and well-being, our lives, and livelihoods. As a subscriber, you aren’t solely a beneficiary of our work but in addition its enabler.
We additionally reiterate right here the promise that our staff of reporters, copy editors, fact-checkers, designers, and photographers will ship high quality journalism that stays away from vested curiosity and political propaganda.
Suresh Nambath
[ad_2]
